ECOR
electroCore, Inc. NASDAQ$6.68
Mkt Cap $54.0M
52w Low $4.16
56.2% of range
52w High $8.64
50d MA $6.58
200d MA $5.76
P/E (TTM)
-4.0x
EV/EBITDA
-3.5x
P/B
—
Debt/Equity
-5.5x
ROE
817.2%
P/FCF
-4.6x
RSI (14)
—
ATR (14)
—
Beta
0.60
50d MA
$6.58
200d MA
$5.76
Avg Volume
60.3K
About
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeab…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2026 | AMC | -0.35 | -0.34 | +2.9% | 6.56 | -2.3% | -4.7% | -6.6% | -5.9% | +2.0% | -8.2% | — |
| Nov 5, 2025 | AMC | -0.36 | -0.40 | -11.1% | 4.74 | +4.9% | +23.2% | +23.0% | +31.2% | +32.9% | +27.8% | — |
| Aug 6, 2025 | AMC | -0.32 | -0.35 | -9.4% | 6.93 | -17.6% | -29.1% | -33.3% | -37.8% | -35.4% | -25.8% | — |
| May 7, 2025 | AMC | -0.56 | -0.47 | +16.1% | 6.81 | -14.8% | -23.8% | -31.7% | -29.2% | -30.7% | -32.3% | — |
| Mar 12, 2025 | AMC | -0.34 | -0.40 | -17.6% | 13.00 | -9.8% | -26.5% | -34.2% | -36.5% | -35.5% | -38.4% | — |
| Nov 13, 2024 | AMC | -0.29 | -0.31 | -6.9% | 13.40 | -12.3% | +1.5% | -18.4% | -28.0% | -24.7% | -25.8% | — |
| Aug 7, 2024 | AMC | -0.39 | -0.38 | +2.6% | 6.10 | +3.8% | -1.3% | -7.4% | -0.7% | -3.4% | -2.1% | — |
| May 8, 2024 | AMC | -0.50 | -0.53 | -6.0% | 7.24 | +1.4% | -5.4% | -5.5% | +0.1% | +3.6% | +2.2% | — |
| Mar 13, 2024 | AMC | -0.55 | -0.61 | -10.9% | 6.45 | -3.7% | -5.6% | +2.9% | +8.5% | +7.4% | -1.2% | — |
| Nov 8, 2023 | AMC | -0.64 | -0.68 | -6.2% | 5.77 | +9.4% | +2.8% | -0.5% | -2.9% | +0.2% | +8.0% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 26 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.47 | $7.41 | -0.8% | +9.1% | +5.5% | -2.9% | -5.0% | -10.8% |
| Mar 13 | Ladenburg Thalmann | Maintains | Buy → Buy | — | $13.00 | $11.73 | -9.8% | -26.5% | -34.2% | -36.5% | -35.5% | -38.4% |
| Mar 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $13.00 | $11.73 | -9.8% | -26.5% | -34.2% | -36.5% | -35.5% | -38.4% |
| Dec 18 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $13.93 | $14.73 | +5.7% | +11.1% | +4.2% | +9.6% | +25.8% | +16.7% |
| Mar 14 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $6.45 | $6.21 | -3.7% | -5.6% | +2.9% | +8.5% | +7.4% | -1.2% |
| Jan 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $6.63 | $6.97 | +5.1% | +9.0% | +11.3% | +12.2% | +13.9% | +12.2% |
| Nov 9 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.77 | $6.31 | +9.4% | +2.8% | -0.5% | -2.9% | +0.2% | +8.0% |
| Aug 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.43 | $5.16 | -5.0% | -8.8% | -9.6% | -9.4% | -6.4% | -12.2% |
| May 4 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $6.00 | $5.96 | -0.7% | -5.0% | -4.0% | +0.8% | +0.3% | -4.5% |
| Apr 18 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $6.91 | $7.16 | +3.6% | -4.6% | -1.3% | -3.3% | -0.9% | -2.6% |
Recent Filings
Data updated apr 25, 2026 6:22am
· Source: massive.com